Navigation Links
For Kids With Leukemia, Radiation May Be Safe to Skip
Date:6/24/2009

Today's chemotherapy regimen often is enough, study finds

WEDNESDAY, June 24 (HealthDay News) -- Radiation to the brain isn't necessary for most children with newly diagnosed acute lymphoblastic leukemia, new research has found.

In fact, doctors from St. Jude Children's Research Hospital found that children who had chemotherapy alone had a longer remission period and experienced fewer adverse events than those who, in the past, had also been given radiation treatments.

"Effective chemotherapy can cure up to 90 percent of all children with acute lymphoblastic leukemia without the use of cranial irradiation," said study author Dr. Ching-Hon Pui, chairman of oncology at the hospital, in Memphis, Tenn.

"Survivors of childhood acute lymphoblastic leukemia can now enjoy excellent quality of life, virtually similar to that of the general population," Pui said.

The study is reported in the June 25 issue of the New England Journal of Medicine.

Leukemia, a cancer that begins in the bone marrow and affects blood cells, is the most common type of cancer affecting children and teens, according to the American Cancer Society. Acute lymphoblastic leukemia (ALL) is the most common type of childhood leukemia, affecting about three out of every four children with the disease.

Historically, treatment included chemotherapy plus preventive radiation of the brain, according to Pui. And, though the addition of radiation was believed to improve survival, the treatment had serious side effects, including an increased risk for another cancer, cognitive deficits and growth retardation.

Chemotherapy regimens have improved over time, but fear remained that not giving children radiation would mean that residual cancer cells might be missed, allowing the leukemia to return.

The study included the evaluation of 71 children who, in the past, would have received preventive cranial radiation but now were being treated with systemic chemotherapy or chemotherapy administered intrathecally (through a lumbar puncture). They were compared with 56 youngsters who had been treated with prophylactic cranial radiation for ALL.

The five-year remission rate for the chemotherapy-only group was 90.8 percent, vs. 73 percent for the group also given radiation treatment. Eleven children in the chemotherapy group had central nervous system relapses, but all were able to achieve a second remission.

"With effective chemotherapy, prophylactic cranial irradiation can be safely omitted in all children with acute lymphoblastic leukemia," Pui said.

Dr. A. Kim Ritchey, chief of the division of pediatric hematology/oncology at Children's Hospital of Pittsburgh, said that the study "may not be the final answer, but my personal bias has always been to decrease radiation as much as possible."

"The treatment of leukemia has become more and more individualized, and high-risk patients can get more therapy, sometimes even based on their genotype, and this study makes the point that you can attempt to treat high-risk patients without cranial radiation," he said. "This is the type of data we love to see in pediatric oncology because we're very concerned about the effects of treatment after the cure."

More information

The American Cancer Society has more on the treatment of childhood acute lymphoblastic leukemia.



SOURCES: Ching-Hon Pui, M.D., chairman, department of oncology, St. Jude Children's Research Hospital, Memphis, Tenn.; A. Kim Ritchey, M.D., chief, division of pediatric hematology/oncology, Children's Hospital of Pittsburgh; June 25, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Informational handout key to giving parents a better understanding of CT radiation risks
2. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
3. Different method of evaluating the urinary tract system reduces radiation dose
4. Radiation and drug combo helps boost efficacy of lung cancer treatment
5. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
6. Radiation therapy technique reduces length of prostate cancer treatment
7. Radiation therapy technique reduces length of prostate cancer treatment
8. Jefferson radiation oncologists use real-time system to plant seeds against cancer
9. Radiation Therapy Services Acquires North Carolina Facility
10. NASA, NSBRI Select 17 Proposals in Space Radiation Research
11. Breast Cancer Radiation Wont Hurt Immune Health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
For Kids With Leukemia, Radiation May Be Safe to Skip
(Date:5/25/2016)... ... 25, 2016 , ... Today Omega Institute, a leading destination for yoga education ... training opportunities in the growing field of yoga therapy . Yoga therapy ... with specific health issues—including injuries, illnesses, and temporary or chronic health conditions. , “Yoga ...
(Date:5/25/2016)... ... 2016 , ... DKT International, one of the largest private ... to release their 2015 global impact data. In 2015, DKT served over 30 ... and 3.8 million unsafe abortions across 21 countries worldwide. , “We are ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... supporting the real time adjudication of medical service claims by Pharmacy Benefit Managers ... current medical claims management software. The TransactRx Cross Benefit Clearinghouse receives standard professional ...
(Date:5/25/2016)... FRANCISCO, CA (PRWEB) , ... May 25, 2016 , ... ... School of Nursing and Health Professions. She will lead a team of more than ... Team. Baker will begin her role as dean in late August. , Baker comes ...
(Date:5/25/2016)... BEACH COUNTY, FLA (PRWEB) , ... May 25, 2016 , ... ... the latest technology to help turn back the hands of time of female aging. ... female aging and childbirth. Women with symptoms such as leakage, laxity, itchiness and ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 Celsion Corporation (NASDAQ: ... today provided an update on its ongoing OVATION ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... is an IL-12 DNA plasmid vector formulated as ...
(Date:5/24/2016)... 24, 2016 ... , la première endoprothèse à double thérapie ... l,intervention portant sur les membres inférieurs et ... OrbusNeich, entreprise mondiale spécialisée dans la fourniture ... vie, a élargi son portefeuille pour inclure ...
(Date:5/23/2016)... According to a new ... Product (Wheelchair, Scooters, Medical Beds, Bathroom Safety, Mechanical, ... Wound), Accessories (Lifting, Transfer) & by End User ... MarketsandMarkets, the patient handling equipment market is expected ... a CAGR of 10.5% during the forecast period ...
Breaking Medicine Technology: